OMEPRAZOLE, HELICOBACTER PYLORI, GASTRITIS, AND DUODENAL ULCER

The Lancet

Volumn 334, Issue 8676, 1989, Pages 1403-

  Biasco, Guido ^a   Miglioli, Mario ^a   Barbara, Luigi ^b   Corinaldesi, Roberto ^b   Febo, GiulioDi ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

DUODENUM ULCER; GASTRITIS; HELICOBACTER PYLORI; LETTER; PRIORITY JOURNAL;

CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; DUODENAL ULCER; GASTRITIS; HUMAN; OMEPRAZOLE;

EID: 0024351141     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(89)92021-7     Document Type: Letter

References (3)

1. Campylobacter pyloridis-associated chronic active antral gastntis: a prospective study on its prevalence and the effects of antibacterial and antiulcer treatment
2. The potential impact of Campylobacter pylon on the treatment of duodenal ulcer disease
3. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high dose ranitidine treatment